Skip to content

The clinical application of huangqi granule combined western medicine treatment of diabetic nephropathy

The clinical application of huangqi granule combined western medicine treatment of diabetic nephropathy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17013482
Enrollment
Unknown
Registered
2017-11-22
Start date
2017-11-30
Completion date
Unknown
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic nephropathy

Interventions

Astragalus particles with ARB group:On the basis of foundation treatment, astragalus particles (no sugar) twice a day, each time the 4 g/package oral
ARB doses for once a day, every time 100 mg orally.
ARB group:On the basis of foundation treatment, ARB doses for once a day, every time 100 mg orally.

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years old; 2. In line with the DN diagnosis, urine trace albumin in 30-300 mg / 24 h, 0.3 3 g / 24 h urine protein quantitative; 3. EGFR greater than 45 ml/min / 1.73 m2; 4. Diabetic nephropathy syndrome differentiation of traditional Chinese medicine in accordance with qi deficiency zhen; 5. Voluntary drug treatment, and signed informed consent.

Exclusion criteria

Exclusion criteria: 1) The patients with malignant tumor; 2) Serious cardiac insufficiency; 3) Pregnancy; 4) Diseases of the immune system or other complications; 5) There is acute or chronic infection, and bilateral renal artery stenosis; 6) Known to the drug allergy patients; 7) In other clinical subjects or other clinical subjects participated in within three months.

Design outcomes

Primary

MeasureTime frame
blood routine;blood biochemistry;24h urine protein quantitation;microalbuminuria;urine routines;glycosylated hemoglobin;blood glucose;IL-6;TNF-a;

Countries

China

Contacts

Public ContactJian Guihua

Shanghai Sixth People's Hospital

1433363218@qq.com+86 13901808238

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026